PortfoliosLab logoPortfoliosLab logo
ISIN
US92214X1063
CUSIP
92214X106
IPO Date
Jan 20, 2017

Highlights

Market Cap
$416.49M
Enterprise Value
$400.79M
EPS (TTM)
-$1.97
Total Revenue (TTM)
$857.50M
Gross Profit (TTM)
$287.70M
EBITDA (TTM)
-$5.80M
Year Range
$6.76 - $14.57
Target Price
$14.50
ROA (TTM)
-7.59%
ROE (TTM)
-17.44%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Varex Imaging Corporation

Often compared with VREX:
VREX vs. ASYS

Performance

VREX Performance Chart

Varex Imaging Corporation (VREX) is down 14.7% since the beginning of the year. At $10 per share, VREX is trading 31.8% below its 52-week high of $15. Investors who bought $1,000 worth of VREX shares 5 years ago would now be looking at an investment worth $389.


Loading charts...

S&P 500 Index

Returns By Period

Varex Imaging Corporation (VREX) has returned -14.68% so far this year and 29.77% over the past 12 months.


Varex Imaging Corporation

1D
-0.90%
1M
-14.38%
YTD
-14.68%
6M
-12.27%
1Y
29.77%
3Y*
-23.60%
5Y*
-17.19%
10Y*

Benchmark (S&P 500 Index)

1D
0.13%
1M
5.25%
YTD
11.16%
6M
11.43%
1Y
28.20%
3Y*
21.12%
5Y*
12.66%
10Y*
13.75%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VREX Monthly Returns History

Based on dividend-adjusted daily data since Jan 20, 2017, VREX's average daily return is 0.00%, while the average monthly return is -0.14%.

Historically, 48% of months were positive and 52% were negative. The best month was Aug 2025 with a return of +58.7%, while the worst month was Aug 2020 at -29.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.

On a daily basis, VREX closed higher 51% of trading days. The best single day was Aug 8, 2025 with a return of +21.4%, while the worst single day was May 13, 2020 at -32.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202619.66%-5.52%-19.44%9.80%-12.19%-2.83%-14.68%
2025-5.83%-6.40%-9.80%-28.28%-7.81%13.04%-16.03%58.65%7.36%-5.73%-1.03%0.69%-20.15%
2024-6.00%-10.74%5.23%-10.22%-4.92%-4.66%0.41%-15.62%-4.49%10.15%27.04%-12.53%-28.83%
20235.86%-17.68%2.83%-2.47%24.24%6.94%-1.19%-15.54%-4.47%-3.94%4.43%8.75%0.99%
2022-17.27%-9.43%-9.94%-6.76%16.07%-7.16%4.21%-5.38%0.24%4.59%-3.93%-4.43%-35.66%
202116.07%18.44%-10.64%15.86%5.69%6.90%1.79%6.85%-3.33%-4.79%6.33%10.51%89.15%

Benchmark Metrics

Varex Imaging Corporation has an annualized alpha of -14.98%, beta of 1.08, and R2 of 0.19 versus S&P 500 Index. Calculated based on daily prices since January 23, 2017.

  • This stock participated in 148.04% of S&P 500 Index downside but only 53.12% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.19 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-14.98%
Beta
1.08
0.19
Upside Capture
53.12%
Downside Capture
148.04%

Return for Risk

Risk / Return Rank

VREX ranks 59 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


VREX Risk / Return Rank: 5959
Overall Rank
VREX Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
VREX Sortino Ratio Rank: 5656
Sortino Ratio Rank
VREX Omega Ratio Rank: 5959
Omega Ratio Rank
VREX Calmar Ratio Rank: 5858
Calmar Ratio Rank
VREX Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Varex Imaging Corporation (VREX) and compare them to S&P 500 Index.


VREXBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.58

2.39

-1.81

Sortino ratio

Return per unit of downside risk

1.12

3.25

-2.14

Omega ratio

Gain probability vs. loss probability

1.16

1.43

-0.27

Calmar ratio

Return relative to maximum drawdown

0.85

3.11

-2.26

Martin ratio

Return relative to average drawdown

2.20

14.38

-12.18

Dividends

Dividend History


Varex Imaging Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Varex Imaging Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Varex Imaging Corporation was 84.16%, occurring on May 9, 2025. The portfolio has not yet recovered.

The current Varex Imaging Corporation drawdown is 77.11%.


Related event

Drawdown

Fall

Recovery

Underwater

2025 selloff2025
-84.16%May 2025
7y 3mo
8y 4moFeb 2018 - now
2017 bear market2017
-21.61%Aug 2017
3mo 15d3mo 14d
6mo 29dApr 2017 - Nov 2017
2017 correction2017
-13.63%Mar 2017
21d29d
1mo 20dFeb 2017 - Apr 2017
2017 pullback2017
-9.73%Jan 2017
4d4d
8dJan 2017 - Jan 2017
2017 pullback2017
-3.51%Dec 2017
0s6d
6dDec 2017 - Dec 2017

Drawdown Indicators


VREXBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-84.16%

-56.78%

-27.38%

Max Drawdown (1Y)

Largest decline over 1 year

-35.10%

-9.10%

-26.00%

Max Drawdown (3Y)

Largest decline over 3 years

-71.14%

-18.90%

-52.24%

Max Drawdown (5Y)

Largest decline over 5 years

-78.77%

-25.43%

-53.34%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-77.11%

0.00%

-77.11%

Average Drawdown

Average peak-to-trough decline

-46.11%

-10.72%

-35.39%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.58%

1.97%

+11.61%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Varex Imaging Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Varex Imaging Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for VREX relative to other companies in the Medical Devices industry. Currently, VREX has a P/S ratio of 0.5. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for VREX in comparison with other companies in the Medical Devices industry. Currently, VREX has a P/B value of 0.9. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with VREX

Add Varex Imaging Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with VREX